FTH: HC Wainwright Initiates Buy
HC Wainwright & Co. initiates coverage on Faeth Therapeutics with a buy rating and a price target of $60
HC Wainwright & Co.
Initiates Coverage On Faeth Therapeutics with Buy Rating, Announces Price Target of $60
HC Wainwright & Co. initiates coverage on Faeth Therapeutics with a buy rating and a price target of $60
HC Wainwright & Co.
Initiates Coverage On Faeth Therapeutics with Buy Rating, Announces Price Target of $60